Study of the pharmacokinetics of Ginkgolide J in rats by ultra-high-performance liquid chromatography tandem mass spectrometry
Open Access
- 31 July 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 1352-1358
Abstract
Background and objective: Ginkgolide J is an active ingredient extracted from Ginkgo biloba leaves and has potential therapeutic effects on Alzheimer’s disease and rheumatoid arthritis. However, its pharmacokinetic behavior remains unclear. As the efficacy of an active ingredient in natural products is significantly affected by its pharmacokinetic characteristics, the pharmacokinetics of Ginkgolide J needs to be elucidated. Materials and methods: A rapid and sensitive quantitative method for Ginkgolide J using ultra-high-performance liquid chromatography-tandem mass spectrometry was established and validated. This method was then applied to pharmacokinetic studies in rats after oral and intravenous administration of a Ginkgolide J solution. Results: The linear range was 2–1000 ng/mL, with a correlation coefficient higher than 0.999. The specificity, precision, accuracy, stability, matrix effect, and recovery rate of this method met the analytical requirements. The pharmacokinetic results showed that the time to maximum plasma concentration (t max ) and half-life (t 1/2 ) after oral administration of Ginkgolide J (10 mg/kg) were 1.50 h and 3.25 h, and t 1/2 after intravenous administration (2 mg/kg) was 1.96 h, respectively. The absolute bioavailability of Ginkgolide J was 8.67%. Compared with intravenous medication, the oral bioavailability of Ginkgolide J is very low; therefore, the development of Ginkgolide J as an intravenous injection is more suitable for clinical applications. Conclusion: In this study, we established a method for analyzing Ginkgolide J based on ultra-high-performance liquid chromatography tandem mass spectrometry and measured its pharmacokinetic behavior in rats. The results showed that the oral bioavailability of Ginkgolide J is very low, and intravenous administration may be necessary for drug development.Keywords
This publication has 24 references indexed in Scilit:
- LC-MS based strategy for chemical profiling and quantification of dispensing granules of Ginkgo biloba seedsHeliyon, 2024
- Isoginkgetin, a bioactive constituent from Ginkgo Biloba, protects against obesity-induced cardiomyopathy via enhancing Nrf2/ARE signalingRedox Biology, 2022
- Efficacy of Diterpene Ginkgolides Meglumine injection in elderly patients with ischemic stroke: A post hoc analysis of a randomized controlled trialPhytomedicine, 2022
- Preparation of a new component group of Ginkgo biloba leaves and investigation of the antihypertensive effects in spontaneously hypertensive ratsBiomedicine & Pharmacotherapy, 2022
- Comparison of phytochemical composition of Ginkgo biloba extracts using a combination of non-targeted and targeted analytical approachesAnalytical and Bioanalytical Chemistry, 2020
- The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature reviewMolecular Medicine, 2019
- Human pharmacokinetics of ginkgo terpene lactones and impact of carboxylation in blood on their platelet-activating factor antagonistic activityActa Pharmacologica Sinica, 2018
- Pharmacokinetics and tissue distribution study of ginkgolide L in rats by ultra-high performance liquid chromatography coupled with tandem mass spectrometryJournal of Chromatography B, 2015
- Pharmacokinetic studies of ginkgolide K in rat plasma and tissues after intravenous administration using ultra-high performance liquid chromatography-tandem mass spectrometryJournal of Chromatography B, 2015
- Protection against β-amyloid induced abnormal synaptic function and cell death by Ginkgolide JNeurobiology of Aging, 2009